Skip to main content

Find Clinical Trials

Home
Conditions
Adjuvant Drug Therapy

Clinical trial condition

Adjuvant Drug Therapy

Explore clinical trials studying Adjuvant Drug Therapy. Study availability and eligibility vary by location and protocol.

5 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Adjuvant Drug Therapy trial results

Recruiting

The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

NCT07502820

Conditions: Adjuvant Drug Therapy, Breast Cancer, Breast Diseases, +5 more
Locations: S:a Älvsborgs Sjukhus Borås, Sweden

Skaraborgs Sjukhus Skövde, Sweden

Capio S:t Görans Sjukhus Stockholm, Sweden

Södersjukhuset, Onkologiska kliniken Stockholm, Sweden

View Trial Details

Recruiting

Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening

NCT07273357

Conditions: Adjuvant Drug Therapy, Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Diseases, +6 more
Locations: Department of Oncology Gävle, Sweden

Department of Oncology Jönköping, Sweden

Department of Oncology Kalmar, Sweden

Department of Oncology Linköping, Sweden

View Trial Details

Recruiting

Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI

NCT07181499

Conditions: Adjuvant Drug Therapy, EGFR, NSCLC
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

The Cancer Center of The Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China

View Trial Details

Not yet recruiting

Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations

NCT07628504

Conditions: Adjuvant Drug Therapy
Locations: Fudan University Shanghai Cancer Center, Shanghai, Shanghai 200032 Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by invitation

Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

NCT06405295

Conditions: Adjuvant Drug Therapy, BRCA Mutation, Breast Carcinoma, +6 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details